Clinical TrialsSearch results
Number of results: 857
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20
Other
- Phase II study of endobronchial ultrasound (EBUS)-guided transbronchial biopsy using thin bronchoscope (XBF-3B260Y1) with miniature probe (XUM-S20-17R) for diagnosis of peripheral pulmonary lesions
- Benign or malignant pulmonary lesions
- Nagoya Medical Center
- 2006-11-01
Other
- Phase II study of dedicated silicone stent placement on the carina between the bronchus to the right upper lobe and bronchus intermedius
- Airway stenotic diseases
- Nagoya Medical Center
- 2009-03-16
Other
- Phase II study of dasatinib and ponatinib switched by molecular response in newly diagnosed BCR-ABL1-positive acute lymphoblastic leukemia
- B-lymphoblastic leukemia/lymphoma with t(9;22)(q34;q11.2):BCR-ABL1
- Dobashi Nobuaki
- 2019-12-13
Other
- Phase II study of cord blood transplantation using myeloablative conditioning in adult patiants (C-SHOT 0603)
- Acute leukemia, Chronic myelogenous leukemia, Myelodysplastic syndrome
- Research Grant on Tissue Engineering from the Japanese Ministry of Health, Labor & Welfare
- 2007-10-29
Other
- Phase II study of Combination of CPT-11 and S-1 for Advanced Non-Small-cell lung cancer
- Previously untreated stageIIIB/IV NSCLC
- West Japan Oncology Group
- 2006-05-04
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II study of cetuximab plus irinotecan for unresectable colorectal cancer
- Unresectable advaned or recurrent colorectal cancer
- Aichi Cancer Center Hospital
- 2009-04-01
Other
- Phase II study of biweekly cetuximab plus irinotecan for unresectable colorectal cancer
- Unresectable colorectal cancer
- Aichi Cancer Center Hospital
- 2009-05-11